Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.55 CAD -2.2% Market Closed
Market Cap: 97.3m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Covalon Technologies Ltd
Research & Development Peer Comparison

Comparables:
B
DRUG
TH
RPTX
AUPH
EDT

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Research & Development
-CA$1.5m
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
-13%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Research & Development
-CA$5m
CAGR 3-Years
-196%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Research & Development
-$16.3m
CAGR 3-Years
15%
CAGR 5-Years
-13%
CAGR 10-Years
-11%
Repare Therapeutics Inc
NASDAQ:RPTX
Research & Development
-$131.8m
CAGR 3-Years
-50%
CAGR 5-Years
-69%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Research & Development
-$33.5m
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
-21%
Spectral Medical Inc
TSX:EDT
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Covalon Technologies Ltd's Research & Development?
Research & Development
-1.5m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Research & Development amounts to -1.5m CAD.

What is Covalon Technologies Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-13%

Over the last year, the Research & Development growth was -39%. The average annual Research & Development growth rates for Covalon Technologies Ltd have been 2% over the past three years , -1% over the past five years , and -13% over the past ten years .

Back to Top